文献速递肿瘤 PET/CT

利用机器学习结合动态18F-FDG PET/CT的代谢与血流特征进行肺癌鉴别诊断

Leveraging machine learning with dynamic 18F-FDG PET/CT: integrating metabolic and flow features for lung cancer differential diagnosis.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-04-04

本研究从187例患者的动态18F-FDG PET/CT原发灶时间活度曲线中提取代谢与血流动力学特征并训练bagging决策树分类模型,交叉验证AUC为0.89,外部42例测试AUC为0.86,均高于SUVmax和Ki。

要点

  • 动态FDG代谢与血流特征组合可区分肺部良恶性病变,交叉验证AUC 0.89。
  • 模型交叉验证AUC 0.89显著高于SUVmax的0.79和Ki的0.76(DeLong p<0.001)。
  • 外部测试集模型AUC 0.86,优于SUVmax的0.72和Ki的0.71。

核心结论

  • 结合动态FDG代谢与血流特征的可解释机器学习模型预测肺部良恶性比SUVmax或净流入率Ki更准确。

研究设计与样本

  • 从187例患者(平均年龄60.41±11.01岁,男性117例)的动态18F-FDG PET/CT原发灶时间活度曲线提取代谢与血流成分特征,训练基于bagging决策树的分类模型并以交叉验证评估。
  • 另用独立数据集42次动态扫描进行外部测试。
  • 采用SHAP评估特征相对重要性,并绘制瀑布图及评估Cohen效应量。

主要发现

  • 交叉验证中模型AUC 0.89、灵敏度0.80、特异度0.88。
  • 交叉验证中SUVmax AUC 0.79(DeLong p<0.001)、Ki AUC 0.76(DeLong检验p<0.001),模型均显著更高。
  • 外部测试集模型AUC 0.86,SUVmax AUC 0.72,Ki AUC 0.71。
  • SHAP识别的最重要特征包括病灶代谢TAC斜率和最大代谢值、AUC及病灶血TAC峰值时间。
  • 瀑布图显示良恶性组预测评分显著不同(p<0.001),Cohen效应量1.71,高于SUV的0.96和Ki的0.81。

关键数值与推荐

  • 交叉验证模型AUC 0.89、灵敏度0.80、特异度0.88。
  • 外部测试集模型AUC 0.86。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dynamic 18F-fluorodeoxyglucose (18F-FDG) PET/CT imaging has been shown to provide additional information for diagnosing lung cancer. The aim of this study was to investigate whether metabolic and flow features directly extracted from time activity curves (TACs) help differentiate between benign and malignant conditions of lung lesions. METHODS: TACs at the primary lesion were extracted from each dynamic 18F-FDG PET/CT scan. The TAC signal was then decomposed into metabolism and blood flow components through kinetic modeling. Dynamic features including area under the curve (AUC), time-to-peak, and slopes were then extracted from each component. The extracted features from 187 patients (mean age, 60.41 ± 11.01 years; 117 males) were used to train a classification model based on bagging, a machine-learning method built with decision trees. The performance of the trained model on differentiating benign and malignant was tested using receiver operating characteristic analysis with cross-validation. External testing was then performed for an independent dataset that consisted of 42 dynamic scans. For the results, SHapley Additive exPlanations (SHAP) were used to assess the relative importance of the contributed features for individuals. Waterfall charts were also plotted, together with assessment of Cohen's effect size to demonstrate the superiority of the proposed model over SUVmax and the net FDG influx rate Ki. RESULTS: The combination of the multiple dynamic features was able to separate benign and malignant lesions. For cross-validation, the trained model had an AUC of 0.89, sensitivity of 0.80, and specificity of 0.88, which was significantly higher than that of either SUVmax (AUC = 0.79, DeLong p < 0.001) or Ki (AUC = 0.76, DeLong test p < 0.001). For the testing dataset, the model had an AUC of 0.86, which again was better than either SUVmax (AUC of 0.72) or Ki (AUC of 0.71). The most important features that contributed to the diagnosis identified by SHAP included the slope and maximum metabolism TAC at the lesion, the AUC, and the peak time of blood TAC at the lesion. The waterfall chart illustrated that the model had significantly different prediction scores between the benign and malignant groups (p < 0.001) with a Cohen's effect size of 1.71, which was higher than that of the values for SUV and Ki (Cohen's effect size 0.96 and 0.81, respectively). CONCLUSION: An explainable machine learning model that combines dynamic FDG metabolic and flow features can predict benign or malignant lung cancer patients more accurately than conventional parameters such as SUVmax or net influx rate Ki.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Yao Z, Wang Y, Wu Y, et al. Leveraging machine learning with dynamic 18F-FDG PET/CT: integrating metabolic and flow features for lung cancer differential diagnosis. Eur J Nucl Med Mol Imaging. 2025. PMID: 40183949. doi:10.1007/s00259-025-07231-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。